WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Related articles:
Related suggestion:
Malaria is still killing people in Kenya, but a vaccine and local drug production may helpWarning over surge in imported malaria in Britain as cases of deadly mosquitoWhen Danish police pulled a woman over, she locked herself in her car and refused to talkChina's cultural tourism embraces immersiveXander Bogaerts has seasonTechnical glitch temporarily closed southern Norway airspace, causing delays at Oslo airportPoland lays claim to a leadership role in Europe as Russia's war threatens stabilityXavi says Barcelona's improved play has been key to changing his mind to leave the clubWhen Danish police pulled a woman over, she locked herself in her car and refused to talkUS applications for jobless claims fall to lowest level in 9 weeks
2.5447s , 6573.921875 kb
Copyright © 2024 Powered by Vertex Pharma scientist talks about the long road to developing non ,Planet Pulse news portal